Anixa Biosciences, Inc.

twitter logo
Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
    • Cancer Business Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • The Future of Cancer Immunotherapy & Women’s Health
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
    • YouTube Channel
  • Contact Us

SEC Filings

Investors

Investors

  • Overview
  • News Releases
  • The Future of Cancer Immunotherapy & Women’s Health
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Fact Sheet
    • Contact IR
    • RSS News Feed
  • SEC Filings

  • Overview
Filter Filings:
Date Form Description Docs XBRL Pages
03/17/11 10-Q Quarterly report pursuant to sections 13 or 15(d)
Related Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 52
02/18/11 SC 13D/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities HTML PDF 6
02/16/11 D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act HTML PDF 5
02/14/11 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.26
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 102
02/14/11 SC 13D/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities HTML PDF 11
02/10/11 8-K Current report filing
Related Documents
EX-10.1
EX-10.2
EX-10.3
EX-99
HTML PDF 45
02/10/11 4 Statement of changes in beneficial ownership of securities HTML PDF 2
02/10/11 4 Statement of changes in beneficial ownership of securities HTML PDF 2
02/10/11 4 Statement of changes in beneficial ownership of securities HTML PDF 2
02/10/11 4 Statement of changes in beneficial ownership of securities HTML PDF 2
RSS
  • << Previous
  • 1...
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • ...94
  • Next >>

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus
twitter logo

Latest News & Events

Sep 2, 2025

Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference

Read More...
Aug 25, 2025

Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Read More...
Aug 20, 2025

Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology

Read More...
Copyrights © 2025 Anixa Biosciences, Inc.. All Rights Reserved.
twitter logo Privacy Policy Terms of Use Disclaimer Sitemap